Clinical Trials on Leiomyoma in Germany

Total 20 results

Bayer

Completed

Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)

Leiomyoma

Germany
University Women's Hospital Tübingen

Active, not recruiting

Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System

One or More Uterine Fibroids

Germany
Bayer

Completed

Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670

Leiomyoma

Germany, Belgium, United Kingdom
Charite University, Berlin, Germany

Completed

Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy

Leiomyoma | Laparoscopic Myomectomy

Germany
Krankenhaus Nordwest

Recruiting

Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy

Uterine Fibroids

Germany
Integra LifeSciences Corporation

Completed

Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy

Myoma | Leiomyoma | Fibroid

Germany
Ethicon, Inc.

Terminated

A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device

Uterine Fibroids

Austria, Germany, Netherlands, Norway
Acessa Health, Inc.

Completed

Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions (LUSTOR)

Uterine Fibroids | Myomas

Germany
Philips Healthcare
Philips Medical Systems

Completed

Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids

Uterine Fibroids

Korea, Republic of, Netherlands, France, Germany
Terumo Europe N.V.

Completed

Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery (ADBEE)

UTERINE MYOMAS

Germany
Gynesonics

Recruiting

Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)

Uterine Fibroid

Germany, Switzerland, United Kingdom
Gynesonics

Completed

Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids (OPEN)

Uterine Fibroids | Adhesions

United Kingdom, Germany, Netherlands, Switzerland
Bayer

Completed

Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap (ASTEROID 1)

Leiomyoma

Belgium, United States, Switzerland, Germany, Spain, Japan, Canada, Finland, Hungary, Bulgaria, Czechia, Norway, Sweden
PregLem SA

Unknown

Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting (Premium)

Uterine Fibroids

Spain, Belgium, Denmark, France, United Kingdom, Italy, Czechia, Germany, Romania, Latvia, Hungary, Lithuania, Netherlands, Poland, Portugal, Sweden
PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIV)

Uterine Fibroids

United Kingdom, Belgium, Czechia, France, Germany, Hungary, Italy, Latvia, Lithuania, Romania, Ukraine
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
PregLem SA

Unknown

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)

Uterine Fibroids

United Kingdom, Spain, Italy, France, Germany, Austria, Hungary, Poland, Portugal, Romania
Bayer

Terminated

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 5)

Uterine Fibroids

Spain, Korea, Republic of, Denmark, Taiwan, Hungary, Lithuania, Austria, Portugal, Germany, Australia, Canada, Sweden, Bulgaria, Czechia, Finland, Norway, Poland, United Kingdom, Belgium, Italy, Slovakia, Netherlands, Ireland
Ethicon, Inc.

Terminated

Uterine Artery Occlusion for Fibroid Related Bleeding

Uterine Fibroids | Menorrhagia

Netherlands, Denmark, France, Germany, Norway, Switzerland, United Kingdom
Bayer

Completed

Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids (ASTEROID 2)

Leiomyoma

Spain, Portugal, Netherlands, Austria, Germany, Hungary, Belgium, Bulgaria, Finland, United Kingdom, Sweden, Poland, Italy, Czech Republic, Lithuania, Norway

Clinical Trials on Leiomyoma in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations